Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment
about
Using Adalimumab Serum Concentration to Choose a Subsequent Biological DMARD in Rheumatoid Arthritis Patients Failing Adalimumab Treatment
description
clinical trial
@en
name
Using Adalimumab Serum Concent ...... s Failing Adalimumab Treatment
@en
type
label
Using Adalimumab Serum Concent ...... s Failing Adalimumab Treatment
@en
prefLabel
Using Adalimumab Serum Concent ...... s Failing Adalimumab Treatment
@en
P1050
P1476
Using Adalimumab Serum Concent ...... d Randomized Superiority Trial
@en
P17
P1813
ADDORA-switch
@en
P3098
NCT04251741
P4844
P580
2020-02-01T00:00:00Z
P582
2022-02-01T00:00:00Z